Bausch Health/$BHC
1D1W1MYTD1Y5YMAX
About Bausch Health
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
- Ticker
- $BHC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 20,300
- Headquarters
- Laval, Canada
- Website
- www.bauschhealth.com
Bausch Health Metrics
BasicAdvanced
$2.4B
-
-$2.95
0.38
-
Price and volume
Market cap
$2.4B
Beta
0.38
52-week high
$8.69
52-week low
$4.33
Average daily volume
4.1M
Financial strength
Current ratio
1.435
Quick ratio
0.9
Long term debt to equity
-2,481.047
Total debt to equity
-2,590.898
Interest coverage (TTM)
1.66%
Profitability
EBITDA (TTM)
3,908
Gross margin (TTM)
71.45%
Net profit margin (TTM)
-10.12%
Operating margin (TTM)
25.21%
Effective tax rate (TTM)
-49.32%
Revenue per employee (TTM)
$530,000
Management effectiveness
Return on assets (TTM)
6.57%
Return on equity (TTM)
333.74%
Valuation
Price to revenue (TTM)
0.218
Price to book
-1.15
Price to tangible book (TTM)
-0.15
Price to free cash flow (TTM)
1.696
Free cash flow yield (TTM)
58.95%
Free cash flow per share (TTM)
3.738
Growth
Revenue change (TTM)
10.09%
Earnings per share change (TTM)
-1,225.87%
3-year revenue growth (CAGR)
9.13%
10-year revenue growth (CAGR)
0.49%
3-year earnings per share growth (CAGR)
79.86%
10-year earnings per share growth (CAGR)
0.17%
What the Analysts think about Bausch Health
Analyst ratings (Buy, Hold, Sell) for Bausch Health stock.
Bausch Health Financial Performance
Revenues and expenses
Bausch Health Earnings Performance
Company profitability
Bausch Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.